Could New Governments In Brazil, Mexico Derail International Regulatory Convergence?
Bayer's Patrick Brady says nationalist sentiments raise concerns, but he remains hopeful that technology and progress will continue to drive globalization.
You may also be interested in...
Latin America Notebook: Advancing Adaptive Trial Designs, Translating ICH Guidelines, Sharing Confidential Information
Brazil's drug regulator ANVISA will require more experience in dealing with adaptive trial designs before issuing guidance; translating older ICH guidelines remains a barrier to their implementation; and industry is asked to be more transparent in sharing their confidential information among drug regulators to facilitate convergence.
Regulatory harmonization is gathering pace in Latin America, which is good news for pharmaceutical companies.
Newly inaugurated Mexican President Andrés Manuel López Obrador may restructure drug regulator in quest to centralize government's public health services.